ASCO-GU 2025: ACCEL trial launch

by ramysaleh.ca | Feb 15, 2025 | Media

Dr. Ramy Saleh presents the ACCEL phase Ia/Ib/II clinical trial—investigating the safety, tolerability, efficacy, and dosimetry of Actinium-225-PSMA-62 in men with oligometastatic hormone-sensitive and metastatic castration-resistant prostate cancer.

The Sarcoma Research Consortium of Quebec

by ramysaleh.ca | May 17, 2024 | Media

Research award created in honour of Quebec man..

by ramysaleh.ca | May 7, 2024 | Media

New award honours late scientist who fought cancer to see his…

by ramysaleh.ca | May 6, 2024 | Media

MUHC trial for potential prostate cancer treatment

by ramysaleh.ca | Apr 11, 2024 | Media

Un essai clinique contre le cancer de la prostate à Montréal

by ramysaleh.ca | Apr 11, 2024 | Media

Un premier patient a été traité mercredi et un deuxième doit l’être jeudi, a confié le docteur Ramy Saleh, qui est oncologue médical au Centre du cancer